Skip to Main Content

The owners of a drug wholesaler have been indicted for their alleged role in a conspiracy to distribute misbranded and diverted HIV pills, the latest effort by federal authorities to target a widespread scheme to pump the medicines into the U.S. pharmaceutical supply chain.

Patrick Boyd and Charles Boyd, who own Safe Chain Solutions, along with a broker, Adam Brosius, were indicted for allegedly buying more than $90 million of “heavily discounted” prescription drugs from a handful of black-market suppliers. Prosecutors said these diverted medicines — mostly HIV pills — were often obtained through unlawful buybacks, in which previously dispensed bottles were purchased from patients.

advertisement

The drugs were then resold to Safe Chain with falsified documentation designed to conceal the true source of the medications, according to the indictment. The indictment further said that, after purchasing HIV medicines from the black-market suppliers, the owners of the wholesaler sold the diverted drugs to pharmacies throughout the U.S. Pharmacies then dispensed the diverted HIV pills to unsuspecting patients.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.